1. Home
  2. AIDX vs NVNO Comparison

AIDX vs NVNO Comparison

Compare AIDX & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 20/20 Biolabs Inc. Common Stock

AIDX

20/20 Biolabs Inc. Common Stock

N/A

Current Price

$0.62

Market Cap

6.7M

Sector

Health Care

ML Signal

N/A

Logo enVVeno Medical Corporation

NVNO

enVVeno Medical Corporation

N/A

Current Price

$11.24

Market Cap

6.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AIDX
NVNO
Founded
N/A
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.7M
6.8M
IPO Year
2025
2017

Fundamental Metrics

Financial Performance
Metric
AIDX
NVNO
Price
$0.62
$11.24
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
86.3K
14.9K
Earning Date
N/A
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
34.48
N/A
EPS
N/A
N/A
Revenue
$2,045,133.00
$31,243.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$140.00
P/E Ratio
N/A
N/A
Revenue Growth
16.71
N/A
52 Week Low
$0.40
$0.30
52 Week High
$14.09
$13.44

Technical Indicators

Market Signals
Indicator
AIDX
NVNO
Relative Strength Index (RSI) 62.70 54.86
Support Level $0.52 $9.66
Resistance Level $0.70 $11.26
Average True Range (ATR) 0.06 0.98
MACD 0.02 0.04
Stochastic Oscillator 86.29 47.03

Price Performance

Historical Comparison
AIDX
NVNO

About AIDX 20/20 Biolabs Inc. Common Stock

20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.

Share on Social Networks: